Table 1.
Clinical characteristics of the sarcoidosis cohort in total and depending on Anti-NELF-E positivity.
| Characteristic | All (n = 82) | Anti-NELF-E IgG (+) (n = 29) |
Anti-NELF-E IgG (−) (n = 53) |
p |
|---|---|---|---|---|
| Age, years (IQR) | 48 (39–59) | 42 (37–54) | 51 (42–59) | 0.123 |
| Female, n (%) | 35 (43) | 13 (45) | 22 (42) | 0.771 |
| Any pulmonary involvement, n (%) | 72 (88) | 25 (86) | 46 (88) | 0.767 |
| Extrapulmonary involvement, n (%) | 48 (59) | 18 (62) | 30 (58) | 0.701 |
| Löfgren-syndrome | 18 (22) | 7 (24) | 11 (21) | 0.757 |
| Xray type | 0.041 | |||
| 0 | 10 (12) | 4 (14) | 6 (12) | |
| I | 7 (9) | 0 | 7 (13) | |
| II | 39 (48) | 18 (62) | 21 (40) | |
| III | 10 (12) | 5 (17) | 5 (10) | |
| IV | 15 (19) | 2 (7) | 13 (25) | |
| Chronic course | 66 (84) | 23 (82) | 43 (84) | 0.803 |